COMMUNIQUÉS West-GlobeNewswire

Ceapro Inc. Confirms Excellent Bioavailability of its New Water Soluble Chemical Complex Coenzyme Q10-Beta Glucan
29/05/2018
Positive results obtained from a unique research protocol and surgical methodology Potential for development of a first-in-class slow-release formulation Results enable Ceapro’s transition to nutraceutical sector by [...]
Novel First-In-Class Immunotherapeutic APVO210 Features Unique Mechanism of Action Delivering IL-10
29/05/2018
Suppresses Inflammation and Immune Activation Without Lymphocyte Stimulation New Preclinical Data Published in ‘Frontiers in Immunology’ Show APVO210 Holds Promise in the Treatment of Autoimmune Diseases by Driving the [...]
GENETIC-AF Phase 2B Clinical Trial Results Presented in Late Breaking Presentation at European Society of Cardiology Heart Failure 2018 World Congress
29/05/2018
End-of-Phase 2 Meeting with the U.S. FDA Scheduled for the Last Week of June to Review Gencaro Phase 2 Data and Future Development Plan WESTMINSTER, Colo., May 29, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: [...]
International Endeavors Corp to launch Canadian distribution of the Off Grid Grow Lab
29/05/2018
TEMECULA, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corp (OTC:IDVV) is pleased to announce that it has made a strategic commitment for the opening of distribution centers in the [...]
Daxor Corporation Retains CORE IR as Investor Relations Firm of Record
29/05/2018
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces it has retained CORE IR [...]
AnaptysBio Presents Updated ANB020 and ANB019 Clinical Data at the 2018 EAACI Congress
29/05/2018
Blood eosinophil level reduction consistent with clinical efficacy in ANB020 Phase 2a atopic dermatitis trial ANB020-mediated eosinophil reduction is aligned with genotypic data from prior human IL-33 loss-of-function [...]
Delcath Systems to Present at the 8th Annual LD Micro Invitational
29/05/2018
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that it will be [...]
Spring Bank to Present at Jefferies 2018 Global Healthcare Conference
29/05/2018
HOPKINTON, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Avinger to Present at the 8th Annual LD Micro Invitational
29/05/2018
REDWOOD CITY, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that it will be presenting at the 8 [...]
Viveve to Present at Jefferies Global Healthcare Conference
29/05/2018
ENGLEWOOD, Colo., May 29, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE ), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive [...]
MPX Raises US$40 Million Secured Convertible Loan to Fund Capacity Development of MPX Assets and Acquisitions
29/05/2018
TORONTO, May 29, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that it has successfully completed a US$40,000,000 secured convertible [...]
iKang Enters into Amendment to Merger Agreement for Going Private Transaction
29/05/2018
BEIJING, May 29, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
Avid Bioservices to Participate at BIO International Convention 2018
29/05/2018
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- -- Company’s Newly Appointed [...]
Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse® (Amifampridine Phosphate) for Lambert-Eaton Myasthenic Syndrome
29/05/2018
--PDUFA Date Set for November 28, 2018 CORAL GABLES, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and [...]
BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology
29/05/2018
Houston location provides access to state-of-the-art equipment and support, and close proximity to world class academic research facilities within local university medical and science centers, as Company continues [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conference
29/05/2018
WALTHAM, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that management will participate in the Jefferies 2018 Healthcare Conference on Tuesday, June 5 th at 3:30 p.m [...]
Abiomed to Present at the Jefferies 2018 Healthcare Conference
29/05/2018
DANVERS, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief [...]
Albireo to Present at Jefferies 2018 Global Healthcare Conference
29/05/2018
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]
BioCryst Announces Presentation of Additional Analyses of the APeX-1 Clinical Trial of BCX7353 at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Congress
29/05/2018
RESEARCH TRIANGLE PARK, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]

Pages